Sage Journals: Discover world-class research

Retricted access

Research article

First published 2020-1

Dalfampridine benefits ambulation but not cognition in multiple sclerosis

Nikhil Satchidanand, Allison Drake, A Smerbeck [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2011-3

Treatment of walking impairment in multiple sclerosis with dalfampridine

Andrew R. Blight

Therapeutic Advances in Neurological Disorders

Retricted access

Review article

First published 2012-7

Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis

Theodore E Pikoulas, Matthew A Fuller

Annals of Pharmacotherapy

Open access

Research article

First published 2018-7

Objective and subjective measures of dalfampridine efficacy in clinical practice

Sylvia Klineova, Rebecca Farber, Joshua Friedman [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Review article

First published 2011

Dalfampridine: Review of its Efficacy in Improving Gait in Patients with Multiple Sclerosis

M.A. Sahraian, A.H. Maghzi, M. Etemadifar [...]

Journal of Central Nervous System Disease

Open access

Research article

First published 2017-12

Randomized,Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis

Kateryna Schwartz, Nicholas F Wymbs, Hwa Huang [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2014-5

Dalfampridine improves walking speed,walking endurance,and community participation in veterans with multiple sclerosis: a longitudinal cohort study

Michelle H Cameron, Mary Fitzpatrick, Shannon Overs [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2012-7

Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment

Carrie Hersh, Alex Rae-Grant

Therapeutic Advances in Neurological Disorders

Retricted access

Case report

First published 2019-4

De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine

Emilie Panicucci, Mikael Cohen, Veronique Bourg [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Sustained-release oral dalfampridine appears to have no impact on upper extremity function in people with multiple sclerosis: a randomized controlled trial

Shay Menascu, Lior Frid, Alon Kalron

Therapeutic Advances in Neurological Disorders

Search results